» Articles » PMID: 25834410

Evaluation of Reliability and Validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30, Albanian Version) Among Breast Cancer Patients from Kosovo

Overview
Date 2015 Apr 3
PMID 25834410
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Patients And Methods: A sample of breast cancer patients (n=62 women) were interviewed for the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) in Albanian. Reliability of the questionnaire was considered acceptable if Cronbach's alpha was ≥0.70. Item convergent-discriminant validity was tested through multitrait scaling analysis. Construct validity was tested under the hypotheses that QLQ-C30 interscale correlations would have an acceptable value of ≥0.40 and as well as by known group comparisons assessing differences of patient subgroups with reference to disease stage and education level.

Results: The mean age of the patients was 50 years (standard deviation: 10.9 years). Cronbach's alpha ranged from 0.54 for the cognitive functioning scale to 0.96 for the global health quality of life (GH/QoL) scale. In multitrait scaling analysis, the strength of Spearman's correlations between an item and its own subscale was ≥0.40, with the exception of item 5 (ρ=0.22); results for item discriminant validity were satisfactory, with the exception of item 5, which showed higher correlation with other subscales than with its own physical functioning. The Spearman's interscale coefficients generally were correlated with each other. Results of known group comparisons did not show significant differences in terms of disease stage. Regarding education level, patients with high school/university education had better functional scales scores only in certain subscales compared to other subgroups; furthermore, patients with secondary school education had better GH/QoL compared to other subgroups of patients.

Conclusion: The EORTC QLQ-C30 (v3.0) in Albanian was found to be valid and reliable for women with breast cancer and could be considered as a starting point for further evaluation study.

Citing Articles

Trends in emotional functioning and psychosocial wellbeing in breast cancer survivors: a prospective cohort study using patient-reported outcome measures.

Devarakonda S, Timman R, Bouvy P, Oemrawsingh A, Apon I, Mureau M BMC Womens Health. 2023; 23(1):153.

PMID: 36997924 PMC: 10064532. DOI: 10.1186/s12905-023-02243-0.


Health-related quality of life in women with breast cancer: a review of measures.

Salas M, Mordin M, Castro C, Islam Z, Tu N, Hackshaw M BMC Cancer. 2022; 22(1):66.

PMID: 35033009 PMC: 8760726. DOI: 10.1186/s12885-021-09157-w.


Quality of life among chronic myeloid leukemia patients in the second-line treatment with nilotinib and influential factors.

Nguyen C, Nguyen B, Nguyen T, Petrelli F, Scuri S, Grappasonni I Qual Life Res. 2021; 31(3):733-743.

PMID: 34258697 DOI: 10.1007/s11136-021-02952-9.


Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.

Gadisa D, Gebremariam E, Ali G Health Qual Life Outcomes. 2019; 17(1):182.

PMID: 31830992 PMC: 6909579. DOI: 10.1186/s12955-019-1257-z.


Quality of life in patients treated for anal carcinoma-a systematic literature review.

Sterner A, Derwinger K, Staff C, Nilsson H, Angenete E Int J Colorectal Dis. 2019; 34(9):1517-1528.

PMID: 31324957 DOI: 10.1007/s00384-019-03342-x.


References
1.
Wan C, Tang X, Tu X, Feng C, Messing S, Meng Q . Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients. Breast Cancer Res Treat. 2007; 105(2):187-93. DOI: 10.1007/s10549-006-9443-1. View

2.
Kontodimopoulos N, Ntinoulis K, Niakas D . Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients. Eur J Cancer Care (Engl). 2010; 20(3):354-61. DOI: 10.1111/j.1365-2354.2009.01170.x. View

3.
Hoopman R, Muller M, Terwee C, Aaronson N . Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. Eur J Cancer. 2006; 42(12):1839-47. DOI: 10.1016/j.ejca.2005.08.047. View

4.
Awad M, Denic S, El Taji H . Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations. Ann N Y Acad Sci. 2008; 1138:146-54. DOI: 10.1196/annals.1414.021. View

5.
Hahn E, Rao D, Cella D, Choi S . Comparability of interview- and self-administration of the Functional Assessment of Cancer Therapy-General (FACT-G) in English- and Spanish-speaking ambulatory cancer patients. Med Care. 2008; 46(4):423-31. DOI: 10.1097/MLR.0b013e3181648e6e. View